B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP in Patients with End-Stage Heart Failure Supported by a Left Ventricular Assist Device
Open Access
- 1 September 2004
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 50 (9) , 1670-1672
- https://doi.org/10.1373/clinchem.2003.030510
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the breathing not properly multinational studyAmerican Journal of Kidney Diseases, 2003
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systemsJournal of the American College of Cardiology, 2001
- The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device typesThe Journal of Heart and Lung Transplantation, 2001
- Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantationJournal of the American College of Cardiology, 2001
- Stability of Brain Natriuretic Peptide (BNP) in Human Whole Blood and Plasmacclm, 2000
- Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrationsThe Lancet, 2000
- Stability of brain natriuretic peptide (BNP) in human blood samplesClinica Chimica Acta; International Journal of Clinical Chemistry, 1999
- One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technologyThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976